Physician profile
Saira Adeel
NPI 1417116450
$6,535.67
in general payments reported to CMS, 2019-2025
45 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,222 · 2020: $408 · 2021: $11.29 · 2022: $363 · 2023: $633 · 2024: $1,747 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,531.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,156.68 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $901.63 | 2019-2025 | Tepezza, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $687.06 | 2019-2025 | |
| Abbott Laboratories | $548.03 | 2019-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $264.41 | 2022-2025 | Dexcom G6 Transmitter |
| Valeritas, INC. | $209.11 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $181.16 | 2019-2020 | |
| Lilly USA, LLC | $175.77 | 2019-2024 | Mounjaro, Jardiance |
| Medtronic, INC. | $160.42 | 2022-2025 | Minimed 780g, Intellis Adaptivestim |
| Novartis Pharmaceuticals Corporation | $152.33 | 2022-2024 | |
| Insulet Corporation | $145.56 | 2019-2022 | |
| Sequel Med Tech, LLC | $136.64 | 2025 | Twiist |
| Kowa Pharmaceuticals America, INC. | $125.53 | 2019 | |
| Ibsa Pharma INC. | $124.76 | 2019-2024 | Licart, Tirosint |
| Tandem Diabetes Care, INC. | $121.20 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saira Adeel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.